Early diffuse recurrence of hepatocellular carcinoma after percutaneous radiofrequency ablation: analysis of risk factors

AbstractObjectiveTo evaluate the risk factors affecting early diffuse recurrence within 1 year of percutaneous ultrasound-guided radiofrequency ablation (RFA) for hepatocellular carcinoma (HCC).MethodsOut of 146 patients who received transcatheter arterial chemoembolisation (TACE) for treatment of recurrent HCC after percutaneous ultrasound-guided RFA, we selected 23 patients with early diffuse recurrence. Early diffuse recurrence was defined as three or more new recurrent HCCs within 1 year of initial RFA. As a control group, we selected 23 patients, matched exactly for age and sex, in which there was no local tumour progression or new recurrence after RFA. To analyse the risk factors, we examined patient factors and tumour factors.ResultsRecurrent tumours occurred from 30 to 365 days after RFA (median time, 203 days). Univariate analysis indicated that larger tumour size and poorly defined margin were significant risk factors (P < 0.05). Multivariate analysis indicated that poorly defined margin was a significant risk factor (P < 0.05).ConclusionLarger tumour size and poorly defined margin may be risk factors for early diffuse recurrence of HCC within 1 year of RFA. Tumours with such risk factors should be treated with a combination of TACE to minimise the potential for therapeutic failure.Key Points• Ultrasound-guided radiofrequency ablation (RFA) is widely used for hepatocellular carcinoma (HCC). • Early diffuse recurrence after RFA is an important prognostic factor • The risk factors for recurrence are larger tumour size and poorly defined margins • Tumours with such risk factors should be treated with transarterial chemoembolisation.

[1]  D. Gouma,et al.  Outcome of regional and local ablative therapies for hepatocellular carcinoma: a collective review. , 2005, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[2]  J. Bruix,et al.  Management of hepatocellular carcinoma , 2005, Hepatology.

[3]  W. Lau,et al.  A Prospective Randomized Trial Comparing Percutaneous Local Ablative Therapy and Partial Hepatectomy for Small Hepatocellular Carcinoma , 2006, Annals of surgery.

[4]  K. Kotoh,et al.  Scattered and rapid intrahepatic recurrences after radio frequency ablation for hepatocellular carcinoma. , 2005, World journal of gastroenterology.

[5]  Kent-Man Chu,et al.  Hepatic Resection for Hepatocellular Carcinoma An Audit of 343 Patients , 1995, Annals of surgery.

[6]  Steven Gallinger,et al.  Recurrence after liver resection for hepatocellular carcinoma: risk factors, treatment, and outcomes. , 2007, Surgery.

[7]  P. Hsu,et al.  Factors for early tumor recurrence of single small hepatocellular carcinoma after percutaneous radiofrequency ablation therapy. , 2005, World journal of gastroenterology.

[8]  Yoshiyuki Suzuki,et al.  Stepwise Hook Extension Technique for Radiofrequency Ablation Therapy of Hepatocellular Carcinoma , 2002, Oncology.

[9]  F. Garbagnati,et al.  Percutaneous RF interstitial thermal ablation in the treatment of hepatic cancer. , 1996, AJR. American journal of roentgenology.

[10]  A. Sugioka,et al.  Hepatic resection for hepatocellular carcinoma. , 1990, Surgery.

[11]  Risk factors of delay in restoration of hepatic reserve capacity and local recurrence after radiofrequency ablation therapy for hepatocellular carcinoma (HCC). , 2005, Hepatology research : the official journal of the Japan Society of Hepatology.

[12]  K. Shirabe,et al.  Factors linked to early recurrence of small hepatocellular carcinoma after hepatectomy: Univariate and multivariate analyses , 1991, Hepatology.

[13]  Wei-long Zou,et al.  Risk factors for fatal recurrence of hepatocellular carcinoma and their role in selecting candidates for liver transplantation. , 2008, Hepatobiliary & pancreatic diseases international : HBPD INT.

[14]  T. Maekita,et al.  Diffuse intrahepatic recurrence after percutaneous radiofrequency ablation for solitary and small hepatocellular carcinoma , 2009, Hepatology international.

[15]  Hajime Nawata,et al.  A multi‐step, incremental expansion method for radio frequency ablation: optimization of the procedure to prevent increases in intra‐tumor pressure and to reduce the ablation time , 2005, Liver international : official journal of the International Association for the Study of the Liver.

[16]  T. Seki,et al.  Rapid progression of hepatocellular carcinoma after transcatheter arterial chemoembolization and percutaneous radiofrequency ablation in the primary tumour region. , 2001, European journal of gastroenterology & hepatology.

[17]  G. Tiberio,et al.  Aggressive recurrence after radiofrequency ablation of liver neoplasms. , 2003, Hepato-gastroenterology.

[18]  A. Ruzzenente,et al.  Rapid progression of hepatocellular carcinoma after Radiofrequency Ablation. , 2004, World journal of gastroenterology.

[19]  Yoshio Yamaoka,et al.  Risk factors for early death due to recurrence after liver resection for hepatocellular carcinoma: Results of a multicenter study , 2004, Journal of surgical oncology.

[20]  K. Kang,et al.  [Risk factors for early recurrence after surgical resection for hepatocellular carcinoma]. , 2008, The Korean journal of hepatology.

[21]  Kunio Okuda,et al.  Primary liver cancers in Japan , 1980, Cancer.

[22]  H. Rhim,et al.  Systematic review of randomized trials for hepatocellular carcinoma treated with percutaneous ablation therapies , 2009, Hepatology.

[23]  H. Wang,et al.  Risk factors for immediate post-operative fatal recurrence after curative resection of hepatocellular carcinoma. , 2006, World journal of gastroenterology.

[24]  K. Kotoh,et al.  High relative fat-free mass is important for maintaining serum albumin levels in patients with compensated liver cirrhosis. , 2005, World journal of gastroenterology.

[25]  T. Kawabe,et al.  A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma. , 2005, Gastroenterology.

[26]  S. Gallinger,et al.  Factors associated with early recurrence after resection for hepatocellular carcinoma and outcomes. , 2006, Journal of the American College of Surgeons.

[27]  F. X. Bosch,et al.  Epidemiology of Primary Liver Cancer , 1999, Seminars in liver disease.

[28]  K. Takeda,et al.  Radiofrequency ablation combined with chemoembolization for the treatment of hepatocellular carcinomas larger than 5 cm. , 2009, Journal of vascular and interventional radiology : JVIR.

[29]  I. Ng,et al.  The pathological basis of resection margin for hepatocellular carcinoma , 1993, World Journal of Surgery.

[30]  E. Kim,et al.  Early Recurring Hepatocellular Carcinoma after Partial Hepatic Resection: Preoperative CT Findings , 2000, Korean journal of radiology.

[31]  K. Sung,et al.  Medium-Sized (3.1–5.0 cm) Hepatocellular Carcinoma: Transarterial Chemoembolization Plus Radiofrequency Ablation Versus Radiofrequency Ablation Alone , 2011, Annals of Surgical Oncology.